Mueller T, Yamamoto T, Fischer A B. "Method for the Synthesis of Ethyl 2-(5-chloro-7-methylimidazo[1,2-a]pyrimidin-2-yl)acetate" [P]. US Patent, US 9637638 B2, 2023-04-23.
发明人张德明,马晓峰,李文辉. "A Process for Preparing High-Purity Ethyl 2-(5-chloro-7-methylimidazo[1,2-a]pyrimidin-2-yl)acetate" [P]. 中国发明专利, 专利号 CN 114776632 B, 授权公告日 2023-09-11.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2024, 1504, 8519-8527.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2018, 530, 9533-9552.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 2-(5-chloro-7-methylimidazo[1,2-a]pyrimidin-2-yl)acetate Using HRMS and NMR". J. Chromatogr. A, 2019, 707, (10), 7655-7664.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 1570, 8708-8729.